Lloyd G Mitchell

This inventor holds 16 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 6 EPO patents. Top assignees: North Carolina State University, Intronn Holdings, LLC, University of Pennsylvania. Active years: 1998-2026.

USPTO Granted Patents = 16 (Patent Applications = 1)

% Patents Active = 50.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 2.2

ph-index = 5

Forward Citations = 201(Granted Patents)

Location History:

Durham, NC (US) (2000 - 2016)
Bethesda, MD (US) (1998 - 2021)

Company Filing History:

5 out of 1,488

North Carolina State University

patents

2 out of 2

Intronn Holdings, LLC

patents

2 out of 2,651

University of Pennsylvania

Proteome Sciences Plc

patents

7. 1 out of 1,217

The United States of America as Represented by the Department of Health

9. 2 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12616757 - Compositions and Methods for Correction of Heritable Ocular Disease (2026-05-05),

2. 10987433 - Compositions and methods for correction of heritable ocular disease (2021-04-27),

3. 9273149 - Methods and compositions for determining the purity of chemically synthesized nucleic acids (2016-03-01),

4. 8735366 - Pre-MRNA trans-splicing molecule (RTM) molecules and their uses (2014-05-27),

5. 8697355 - Methods and compositions for determining the purity of chemically synthesized nucleic acids (2014-04-15),

6. 8323910 - Methods and compositions for determining the purity of chemically synthesized nucleic acids (2012-12-04),

7. 8173377 - Methods and compositions for determining the purity of chemically synthesized nucleic acids (2012-05-08),

8. 8076461 - Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids (2011-12-13),

9. 8053232 - Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing (2011-11-08),

10. 7901892 - Methods and compositions for determining the purity of chemically synthesized nucleic acids (2011-03-08),

11. 7399753 - Trans-splicing mediated photodynamic therapy (2008-07-15),

12. 6673621 - Sample collection devices and methods using markers and the use of such markers as controls in sample validation, laboratory evaluation and/or accreditation (2004-01-06),

13. 6280978 - Methods and compositions for use in spliceosome mediated RNA trans-splicing (2001-08-28),

14. 6083702 - Methods and compositions for use in spliceosome mediated RNA (2000-07-04),

15. 6013487 - Chimeric RNA molecules generated by trans-splicing (2000-01-11),

Title: The Inventor Profile of Lloyd G Mitchell

Introduction: Lloyd G Mitchell is a renowned inventor based in Bethesda, MD, known for his innovative contributions to various industries.

Latest Patents: Lloyd G Mitchell holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: Throughout his career, Lloyd G Mitchell has been recognized for his groundbreaking inventions that have significantly impacted the way we live and work. His dedication to pushing the boundaries of innovation has led to numerous successful ventures.

Collaborations: Lloyd G Mitchell has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His ability to work across disciplines has resulted in the development of cutting-edge technologies.

Conclusion: Lloyd G Mitchell's passion for innovation and his relentless pursuit of excellence make him a standout figure in the world of inventors. His contributions continue to inspire future generations of inventors and innovators.